Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

TCP1 alpha/CCTA Antikörper (AA 3-106)

Der Maus Monoklonal Anti-TCP1 alpha/CCTA-Antikörper wurde für WB, IF und FACS validiert. Er ist geeignet, TCP1 alpha/CCTA in Proben von Human zu detektieren.
Produktnummer ABIN6189951

Kurzübersicht für TCP1 alpha/CCTA Antikörper (AA 3-106) (ABIN6189951)

Target

Alle TCP1 alpha/CCTA (TCP1) Antikörper anzeigen
TCP1 alpha/CCTA (TCP1) (T-Complex 1 (TCP1))

Reaktivität

  • 216
  • 138
  • 86
  • 21
  • 21
  • 20
  • 19
  • 17
  • 17
  • 15
  • 13
  • 11
  • 10
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 170
  • 48
  • 26
  • 1
  • 1
Maus

Klonalität

  • 149
  • 97
Monoklonal

Konjugat

  • 78
  • 18
  • 12
  • 10
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Dieser TCP1 alpha/CCTA Antikörper ist unkonjugiert

Applikation

  • 130
  • 72
  • 54
  • 53
  • 52
  • 46
  • 44
  • 44
  • 41
  • 24
  • 22
  • 12
  • 11
  • 2
  • 1
Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS)

Klon

TP63-1786
  • Bindungsspezifität

    • 39
    • 18
    • 18
    • 15
    • 15
    • 15
    • 15
    • 9
    • 5
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 3-106

    Verwendungszweck

    Mouse Monoclonal anti-p63 (TP63/1786), Purified, with BSA

    Produktmerkmale

    p63 is a homolog of the tumor suppressor p53. It is identified in basal cells in the epithelial layers of a variety of tissues, including epidermis, cervix, urothelium, breast and prostate. p63 was detected in nuclei of the basal epithelium in normal prostate glands, however, it was not expressed in malignant tumors of the prostate. As a result, p63 has been reported as a useful marker for differentiating benign from malignant lesions in the prostate, particularly when used in combination with markers of high molecular weight cytokeratins and the prostate-specific marker AMACR (P504S). p63 has also been shown to be a sensitive marker for lung squamous cell carcinomas (SqCC), with a sensitivity of ~90 % . Specificity for lung SqCC, vs. lung adenocarcinoma (LADC), is approximately 80 %. In breast tissue, p63 has been identified in myoepithelial cells of normal ducts. Primary antibodies are available purified, or with a selection of fluorescent CF® dyes and other labels. CF® dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

    Aufreinigung

    Purified

    Immunogen

    Recombinant human p63 protein fragment (aa3-106) (exact sequence is proprietary)

    Isotyp

    IgG2b kappa
  • Applikationshinweise

    Flow Cytometry 0.5-1 μg/million cells/0.1 mL
    • Immunofluorescence 1-2 μg/mL
    • Western blotting 0.5-1 μg/mL
    • Optimal dilution for a specific application should be determined by user

    Kommentare

    HEK293 cells or Prostate Carcinoma or Lung or bladder squamous cell carcinoma

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    200 μg/mL

    Buffer

    PBS/0.05 % BSA/0.05 % azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
  • Target

    TCP1 alpha/CCTA (TCP1) (T-Complex 1 (TCP1))

    Andere Bezeichnung

    p63

    Molekulargewicht

    63 kDa

    Gen-ID

    8626, 137569

    UniProt

    Q9H3D4
Sie sind hier:
Chat with us!